Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,760 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Protocol letter: Intra-treatment Image Guided Adaptive Radiotherapy Dose-escalation Study (InGReS) - A Phase 1 multicentre feasibility study.
Adjogatse D, Michaelidou A, Sanchez Nieto B, Kozarski R, Sassoon I, Evans M, Rackley T, Shah S, Eaton D, Pike L, Curry S, Gould SM, Thomas C, Kong A, Petkar I, Reis-Ferreira M, Connor S, Barrington SF, Lei M, Guerrero Urbano T. Adjogatse D, et al. Among authors: kong a. Radiother Oncol. 2023 Jun;183:109645. doi: 10.1016/j.radonc.2023.109645. Epub 2023 Mar 28. Radiother Oncol. 2023. PMID: 36997123 No abstract available.
Drug-dependent inhibition of nucleotide hydrolysis in the heterodimeric ABC multidrug transporter PatAB from Streptococcus pneumoniae.
Guffick C, Hsieh PY, Ali A, Shi W, Howard J, Chinthapalli DK, Kong AC, Salaa I, Crouch LI, Ansbro MR, Isaacson SC, Singh H, Barrera NP, Nair AV, Robinson CV, Deery MJ, van Veen HW. Guffick C, et al. Among authors: kong ac. FEBS J. 2022 Jul;289(13):3770-3788. doi: 10.1111/febs.16366. Epub 2022 Feb 11. FEBS J. 2022. PMID: 35066976 Free PMC article.
PTPN9 regulates HER3 phosphorylation during trastuzumab treatment and loss of PTPN9 is a potential biomarker for trastuzumab resistance in HER2 positive breast cancer.
Azad A, Arshad M, Generali D, Feldinger K, Gijsen M, Strina C, Cappelletti M, Andreis D, Leek R, Haider S, Kellokumpu-Lehtinen PL, Roxanis I, Harris AL, Shaaban AM, Joensuu H, Kong A. Azad A, et al. Among authors: kong a. Cancer Commun (Lond). 2024 Nov 24. doi: 10.1002/cac2.12632. Online ahead of print. Cancer Commun (Lond). 2024. PMID: 39582148 No abstract available.
A polygenic risk score derived from common variants of monogenic diabetes genes is associated with young-onset type 2 diabetes and cardiovascular-kidney complications.
O CK, Fan B, Tsoi STF, Tam CHT, Wan R, Lau ESH, Shi M, Lim CKP, Yu G, Ho JPY, Chow EYK, Kong APS, Ozaki R, So WY, Ma RCW, Luk AOY, Chan JCN. O CK, et al. Among authors: kong aps. Diabetologia. 2024 Nov 23. doi: 10.1007/s00125-024-06320-3. Online ahead of print. Diabetologia. 2024. PMID: 39579208
1,760 results